You are here:  Home  >  Health & Living  >  Current Article

Anal cancer rising worldwide, says American Cancer Society

By   /   November 12, 2016  /   Comments Off on Anal cancer rising worldwide, says American Cancer Society

A new American Cancer Society study finds that incidence of anal cancer has been

increasing in women or in both men and women in 13 of 18 countries studied,

particularly in the Americas, Northern and Western Europe, and Australia.

The authors say population-based preventive measures, including human

papillomavirus vaccination and advocacy for safe sexual behaviors, may help curb the

surging burden of the disease. The study is published early online in the International

Journal of Epidemiology.

Anal cancer is relatively rare, often-neglected cancer.

The most recent estimates (2008) were that only about 27,000 cases occurred

worldwide (14,500 cases in women and 12 500 in men).

Previous studies have reported a relatively rapid increase in the incidence rate in some

very high-income countries. However, trends elsewhere are largely unknown.

The current study, led by Farhad Islami, M.D., Ph.D., strategic director of cancer

surveillance research at the American Cancer Society, used the latest data using data

from the International Agency for Research on Cancer’s Cancer Incidence in Five

Continents series to estimate anal cancer incidence in 18 countries in four continents

(excluding Africa), including several countries that are economically less developed than

those studied previously.

They found incidence of anal cancer has been increasing—either in both sexes or in

women—in many populations, especially in the Americas, Northern and Western

Europe, and Australia. In those populations, one subtype, anal squamous cell

carcinoma (ASCC) was substantially more common than others, and was the main

contributor to the increase in incidence. Incidence for the other major subtype, anal

adenocarcinoma (AAC) has been stable or decreasing in most populations.

“The reason for the increasing ASCC incidence rates in many populations is unclear,

but is likely to reflect changes in prevalence of environmental risk factors,” say the

authors. Those include infection with human papilloma virus (HPV), which is found in

almost all cases of ASCC.

While HPV vaccination can provide protection against anal HPV infection, the authors

note that it is

probably too early to see preventive effects of vaccination of young adults on anal

cancer incidence rates. Also, the vaccine is either not routinely administered or uptake

is suboptimal in countries.

“Certain preventive measures if implemented, including HPV vaccination and

campaigns for safer sexual behaviors, would serve to prevent a substantial number of

anal cancer cases in the future,” the authors conclude.

    Print       Email

You might also like...

International Naturopathy Organisation conducts annual meeting at SPPC

Read More →